Why the study?
While obesity is an established CVD risk factor, higher BMI is linked to improved prognosis in chronic CVD (obesity survival paradox), prompting an examination of the relationships between obesity, cardiorespiratory fitness, and CVD.
Does increased cardiorespiratory fitness improve cardiovascular prognosis and attenuate the obesity paradox in patients with cardiovascular disease?
Does increased cardiorespiratory fitness improve cardiovascular prognosis and attenuate the obesity paradox in patients with cardiovascular disease?
Cardiorespiratory fitness is a vital component of health that mitigates cardiovascular risk and improves prognosis, largely attenuating the obesity survival paradox.
Supports fitness assessment in obese CVD patients; leaves open whether interventions modify the obesity paradox in trials.
PURPOSE OF REVIEW: Obesity, generally defined by body mass index (BMI), is an established risk factor for the development of cardiovascular disease (CVD), while cardiorespiratory fitness (CRF) decreases risk. In chronic CVD, an obesity survival paradox in which higher BMI is associated with improved prognosis has been reported. This paper will examine the effect of obesity on CVD risk, explore obesity as a risk factor in patients with established CVD, and investigate the relationship between CRF, obesity, and CVD. RECENT FINDINGS: Through metabolic and hemodynamic changes, obesity increases the risk for CVD and contributes to the development of other cardiovascular risk factors such as diabetes, dyslipidemia, and hypertension. Obesity is associated with metabolic, hormonal, and inflammatory changes that leads to atherosclerosis increasing the risk for coronary artery disease, and myocardial remodeling increasing the risk for heart failure. However, it has also been observed that overweight/obese patients with established CVD have a better prognosis when compared to non-obese individuals termed the obesity paradox. CRF is a vital component of health associated with improved cardiovascular outcomes and furthermore has been shown to markedly attenuate or nullify the relationship between obesity and CVD risk/prognosis. Increasing CRF mitigates CVD risk factors and improves overall prognosis in CVD regardless of obesity status.
No takes yet. Share an insight, caveat, or question.
Haidar et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: